UBE2T and nonpapillary renal cell carcinoma: In malignant melanoma, miR-498 inhibits progression by targeting UBE2T [22], while in clear cell renal cell carcinoma (ccRCC), miR-182-5p suppresses UBE2T protein expression, thereby inhibiting cell proliferation, migration, and invasion by targeting UBE2T mRNA [124].